Latest News

Vaccine Supply Update

Monday, June 19, 2017


GSK is experiencing a reduced manufacturing capacity for hepatitis A and B antigens, which is impacting our ability to supply Adult PFS presentations of Havrix Monodose (Hepatitis A (inactivated) vaccine (adsorbed)) and Engerix B (Hepatitis B (rDNA) vaccine (adsorbed) (HBV)).

Havrix

We anticipate supply constraints on Havrix Adult PFS from June until August. Havrix Adult PFS will then be out of stock from August 2017 until early 2018.

Engerix B

We anticipate being out of stock of Engerix B Adult PFS from August 2017 until early 2018. We anticipate having limited supply of Engerix B Adult vials for the rest of the year. Engerix B Paediatric is in stock and no supply issues are anticipated.

Twinrix (Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed))

For patients requiring vaccination against hepatitis A and B, Twinrix is available in single and 10 pack presentations. No supply constraints are currently predicted.

Please find below a full supply overview for vaccines not in the UK UMV (Universal Mass Vaccination) programme, including Ambirix (Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)), Rabipur (Rabies vaccine, inactivated), Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine), Varilrix (live attenuated varicella-zoster virus vaccine) and Bexsero (Meningococcal group B Vaccine (rDNA, component, adsorbed)):